Antidepressant Coalition for Education

There are hundreds of thousands of members in withdrawal-related support groups and that figure does not include the countless individuals who never formally joined these communities or those who suffered in isolation, never finding them at all.

It is a profound failure that drug manufacturers and regulators did not adequately warn patients—people who simply trusted their doctors—about the possibility of severe, life-altering withdrawal and the need for careful, often years-long tapering. For many long-term users, tapering is not a passive process. It requires measuring tiny amounts of medication—crumbs, beads, or drops—with extraordinary precision to avoid debilitating symptoms.

In the absence of meaningful medical guidance, patients have become the experts, creating makeshift laboratories in their kitchens and developing tapering methods through necessity and lived experience. Attempts to dismiss these experiences as mere anecdote, or to discredit patients’ accounts of their own bodies and minds because they carry a psychiatric diagnosis, are fundamentally anti-patient. Those most affected by these drugs deserve to be heard, not silenced.